tradingkey.logo
tradingkey.logo
검색

OptimizeRx Corp

OPRX
관심 목록에 추가
6.190USD
+0.110+1.81%
종가 07/02, 13:00ET시세는 15분 지연됩니다
116.16M시가총액
16.76P/E TTM

자세한 내용은 OptimizeRx Corp 회사

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corp 정보

종목 코드 OPRX
회사 이름OptimizeRx Corp
상장일May 18, 2005
CEOSilvestro (Stephen L)
직원 수106
유형Ordinary Share
회계 연도 종료May 18
주소260 Charles Street
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02453
전화12486516558
웹사이트https://www.optimizerx.com/
종목 코드 OPRX
상장일May 18, 2005
CEOSilvestro (Stephen L)

OptimizeRx Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
46.27K
+74.60%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
44.73K
-3.51%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
32.73K
-5.48%
Ms. Lynn O'Connor Vos
Ms. Lynn O'Connor Vos
Independent Chairperson of the Board
Independent Chairperson of the Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%

자주 묻는 질문

OptimizeRx Corp의 상위 5대 주주는 누구인가요?

OptimizeRx Corp의 상위 5대 주주는 다음과 같습니다: Mr. James (Jim) Lang

OptimizeRx Corp(OPRX)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, OptimizeRx Corp의 주식을 보유한 기관은 총 300곳이며, 이들이 보유한 주식의 총 가치는 약 15.47M로 전체 발행 주식의 82.46%를 차지합니다. 이는 2025Q4 대비 -5161941.00 증가한 수치입니다.